David Savastano, Editor01.30.19
The World Health Organisation regards diabetes as a global epidemic. The current global population of diabetics is estimated at 400 million and is set to grow to 500 million by 2020. In the UK alone, there are currently 4 million diabetics and this is expected to grow to 5.5 million by 2020. Currently more than 280,000 people a year are diagnosed with diabetes.
One of the impacts of diabetes is diabetic retinopathy (DR), a disease caused by diabetes. DR is one of the most common causes of blindness in the western world. Most sight loss due to diabetes is preventable if treatment is given early. However, current treatments are prohibitively expensive, highly invasive and present a significant burden to patients and healthcare systems worldwide. Today in many countries, patients are not treated due to the prohibitive cost.
PolyPhotonix is providing an alternative to the present treatme
One of the impacts of diabetes is diabetic retinopathy (DR), a disease caused by diabetes. DR is one of the most common causes of blindness in the western world. Most sight loss due to diabetes is preventable if treatment is given early. However, current treatments are prohibitively expensive, highly invasive and present a significant burden to patients and healthcare systems worldwide. Today in many countries, patients are not treated due to the prohibitive cost.
PolyPhotonix is providing an alternative to the present treatme
Continue reading this story and get 24/7 access to The Independent Global Source for the Flexible and Printed Electronics Industry. for FREE
Stay ahead of the fast growing field of flexible and printed electronics, an emerging industry that promises to revolutionize the methods in which electronic components and systems are manufactured. Flexible and printed electronics covers smart packaging and labels, sensors and wearables, solar cells, displays and lighting, batteries, medical devices, military equipment, and much more.
FREE SUBSCRIPTION
